Equine IL-6 antibody and antigen (recombinant protein)
Diagnostic anti-Equine IL-6 antibodies pairs and antigen for animal health (animal Equine/Horse systemic juvenile idiopathic arthritis, systemic lupus erythematosus, ankylosing spondylitis, psoriasis and Crohn's disease.) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Equine disease testing products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-EQU-IL-6-Ag01 | Equine IL-6 | $3090.00 |
GMP-EQU-IL-6-Ab01 | Anti-Equine IL-6 mouse monoclonal antibody (mAb) | $3090.00 |
GMP-EQU-IL-6-Ab02 | Anti-Equine IL-6 mouse monoclonal antibody (mAb) | $3090.00 |
GMP-EQU-IL-6-Ab03 | Anti-Equine IL-6 human monoclonal antibody (mAb) | $3090.00 |
GMP-EQU-IL-6-Ab04 | Anti-Equine IL-6 human monoclonal antibody (mAb) | $3090.00 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. | GMP-EQU-IL-6-Ag01 |
Product Name | Equine IL-6 |
Target/Biomarker | Equine IL-6 |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Equine IL-6 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in IL-6 level test of animal Equine/Horse with systemic juvenile idiopathic arthritis, systemic lupus erythematosus, ankylosing spondylitis, psoriasis and Crohn's disease.. |
Tag | His | Reconized/Reactive Specics | Equine IL-6 |
Product description | Recombinant Equine IL-6 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. | GMP-EQU-IL-6-Ab01,GMP-EQU-IL-6-Ab02 |
Target/Biomarker | Equine IL-6 |
Product Name | Anti-Equine IL-6 mouse monoclonal antibody (mAb) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Equine IL-6 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine IL-6 antibodies in Equine IL-6 level test of animal Equine/Horse with systemic juvenile idiopathic arthritis, systemic lupus erythematosus, ankylosing spondylitis, psoriasis and Crohn's disease.. |
Product description | Anti-Equine IL-6 mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine IL-6 antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. | GMP-EQU-IL-6-Ab03,GMP-EQU-IL-6-Ab04 |
Target/Biomarker | Equine IL-6 |
Product Name | Anti-Equine IL-6 human monoclonal antibody (mAb) |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | Recombinant Equine IL-6 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine IL-6 antibodies in Equine IL-6 level test of animal Equine/Horse with systemic juvenile idiopathic arthritis, systemic lupus erythematosus, ankylosing spondylitis, psoriasis and Crohn's disease.. |
Product description | Anti-Equine IL-6 mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker Information
Interleukin-6 (IL-6) stands as a multifaceted cytokine in the realm of equine health, playing a pivotal role in immune regulation and inflammation management. This biomarker is produced by a diverse array of cells, including white blood cells (leukocytes), macrophages, and fibroblasts, in response to various physiological stimuli.
In horses, IL-6's functions are diverse and context-dependent. It serves as both a pro-inflammatory and anti-inflammatory cytokine, responding dynamically to the body's needs. During acute infections or tissue injuries, IL-6 is released to trigger an immediate immune response, recruiting immune cells to the site of infection or injury and enhancing their activity. Moreover, IL-6 supports the liver in producing acute-phase proteins, which are essential for the body's defense mechanisms.
However, it's essential to note that prolonged or excessive IL-6 production can lead to chronic inflammation, which is implicated in various diseases, including autoimmune disorders and certain cancers. Dysregulation of IL-6 is associated with health issues, making its measurement in horses a valuable diagnostic tool.
IL-6 levels can be assessed through blood tests, allowing veterinarians to gauge a horse's immune status and inflammatory state. Elevated levels of IL-6 often indicate the presence of inflammation, infections, autoimmune diseases, or other underlying health issues in horses.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.